06 Dec Merck’s PD-1 star Keytruda shines at ASH, but lags behind Bristol-Myers’ rival …read more Source: Merck’s PD-1 star Keytruda shines at ASH, but lags behind Bristol-Myers’ rival 0 No comments admin blog Rare disease could be the gateway to billions for PCSK9 drugs Agios’ AG-221 racks up more cancer remissions, setting the stage for a pivotal challenge
